As of 2026-03-30, 国药集团（国大药房）'s data on the DeepSeek platform in the 医疗保健 category shows: The overall mention rate is 0.00%, below the industry average by 3.6 percentage points, with significant room for improvement. The first mention rate is only 0.00%, it is recommended to enhance first-position exposure in AI model responses. Negative mention rate (0.00%) has exceeded positive (0.00%), it is recommended to immediately initiate reputation repair. Among 4 competitors in the same category, 国药集团（国大药房）'s overall mention rate surpasses 0 brands. AIGeo recommends combining the above data to formulate targeted brand monitoring strategies to further enhance brand visibility and reputation in the AI search ecosystem.
国药集团（国大药房）'s Mention Rate is 0.00%, lower than 0.6% of competitors
国药集团（国大药房）'s First Mention is 0.00%, lower than 0.9% of competitors
国药集团（国大药房）'s Preferred Rate is 0.00%, lower than 100.0% of competitors
国药集团（国大药房）'s Positive Rate is 0.00%, lower than 8.9% of competitors
国药集团（国大药房）'s Negative Rate is 0.00%, higher than 96.3% of competitors
| Competitor | Mention Rate | First Mention | Preferred Rate | Positive Rate | Negative Rate | Actions |
|---|---|---|---|---|---|---|
| 云云南白药 | 14.29% | 0% | 0% | 10.71% | 1.79% | View Details |
| 大大参林 | 0% | 0% | 0% | 0% | 0% | View Details |
| 复复星医药 | 0% | 0% | 0% | 0% | 0% | View Details |
| 恒恒瑞医药 | 0% | 0% | 0% | 0% | 0% | View Details |
| 国国药集团（国大药房） (Current Brand) | 0% | 0% | 0% | 0% | 0% | View Details |
